Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol COME ON MAN! I’m not a noob that the board fear mongers get to prey on with their scare tactics. Sadly...I learned my lesson the hard way many many many moons ago. Hindsight is always 20/20.
Looking back at some of the fear mongering that went on on these stock boards (IHUB, SA, etc), I’m ashamed at what I allowed to rattle me. But as time went on, I realized that as much as I hated to come to terms with it, in the investing game, money makes people do some really terrible things...lie, cheat and steal at all cost.
I’ve been long $EVOK since 2016. I’m averaged in way way way way way lower than the recent prices. If I’m wrong, then congrats to the relatively few short positions. My assumption is that I’m not. We’ll see in t minus 5 hours. Feeling good....ahhhh
With $4.7 million on hand and with a $1.8 million cash burn per qtr. I guess for the shorts that don’t comprehend the basic math: $4.7 cash - ($1.8 x 2 qtrs.) = $1.1 million cash on hand at the end of the year with no offering and no revenue from Gimoti. By the way... this doesn’t however include any potential cost reductions in R&D now that Gimoti is approved. To the naysayers, I will say that it doesn’t mean they won’t need an offering in the 1st QTR of 2021 if sales are stagnant but at that point the potential for a buyout is certainly on the table if not taking place before then, which is most likely the end goal anyway.
$EVOK
Correction....$4.7 million in cash. $EVOK
Clearly short. Everyone here that knows anything about this company understands the woes of the last 4 years. Latest fins show they burn $1.8 per qtr. With $4.1 in cash that’s tells me they have adequate resources available to take us through the end of the year without any revenue coming in from Gimoti which will result in the use of the $5 million dollar line of credit not additional cash burn immediately. Its fine that you are short but understand you lose credibility when your posts clearly outline your strategy of attempting to scare holders of a drop in price. If this drops below after market prices Friday, it would only be temporary. I don’t believes that’s going to happen at all. 6 million shares traded in less than an hour after market closed. When retail market has full access to buy in, $EVOK should shoot straight up. Good luck to you. I’d recommend covering premarket if possible. GLTA
Imagine being short on Friday. That would not be a great feeling rolling into Monday. Run up coming Monday. Lots of eyes here. $EVOK
Agree. I would’ve given an A for effort had this started pre-approval. Certainly would’ve had a better opportunity at an effective campaign. BK? Not likely. Dilution possibly? But I don’t anticipate that happening at this point. If this takes off like we are assuming it will, we will all be happy we held this over the years/months/weeks. GLTA $EVOK
$4.7 million is broke? Since we’re stating “facts”....
“The FDA approval of GIMOTI allows Evoke to access its existing $5 million line of credit from EVERSANA to support manufacturing and other aspects of GIMOTI’s commercialization. As of May 31, 2020, the Company’s cash and cash equivalents were approximately $4.7 million. Evoke believes, based on its current operating plan, that its cash and cash equivalents, together with the EVERSANA line of credit, will support the company’s operations into 2021, without consideration of potential GIMOTI revenue.” $EVOK
Show me a publicly traded biotech company, in its infancy, that doesn’t include a going concern. GTFOH...
$EVOK
Lol close to bankruptcy? Nice one! There are 5 employees. They can do a public offering push come to shove. Sell some shares but they won’t need to. PR today clearly states that they have enough cash to last through end of year without any money from future gimoti sales. Go bark up some other board. $EVOK LONG HERE
Congrats to all the longs that held here! Gimoti gets FDA approval. Where do we go on Monday? Lettttsssss freaakingggg gooooo!!! $EVOK
I’m with you. I’ve been here for....ready for it...around 48 months! Hahaha I’m really hopeful and keeping my fingers crossed, toes crossed, and praying that it gets approval. Not even sure what the market would value the stock at but at $20 a share that gives us a market cap of $500 million. In my opinion, I think that’s completely realistic. I also feel that there’s a compelling case for $40 or $50 per share if its approved and there’s a huge demand for the product. $40 a share would give $EVOK a market cap of $1 billion. I’ll take either. Let’s hope we get a swift approval and see some major momentum following that update. Good luck to all!
Been here for about that long. Is 6/12 the date? I’ve lost track.
Lots of movement as of late though. I’m hopeful to be well above $3 by that time and with news who knows if we test the $10 mark again. With approval I’m not sure what we could be valued at? $10? $20? With aprox 24 million outstanding shares, a $20 price tag would value EVOKE at around $500 million. Doesn’t seem like an unrealistic market cap with approval for a first off its kind drug. Waiting patiently...
$EVOK
In Musclepharm's prime they were THE supplemebt company to compete with. Crazy hype aroubd the brand and akot of noise created by the loyal users. The only thing that is missing from this eqiatuon is leadership. If / when that happens this will turnaround quickly or the other scenario is that a potebtial buyer with those skills scoops this up. $70 million in sales is an attractive bolt on to a well established health and wellness company.
Liking the double from last week levels! If the volume continues, this should run quickly! $MSLP
Glad to see someone fill this roll full time. They had been using a consultant for the past several months or potentially over a year. They’ve got to turn this thing around. Seriously...how hard could it be?
Regardless of current management’s incompetence and abuse of the company, I feel the brand still has a loyal following. BB.com has always been a fairly accurate metric for gauging relevance of a brand. Brad and Cory May have been marketing geniuses...business acumen not so much!
Like to see MSLP at 14. Means we’re still selling products at a fairly significant clip
I know what you mean! I’m sure their sales are struggling but I would assume they still have to be around $75 million in sales but who knows.
So I’m sure someone who knows what the f they’re doing, would be happy to scoop up $75 million in sales for $32 milly.
I mean, their Instagram is tight! I love looking at the warehouse gym that we’ve all helped fund for the celebrities to work out in. Especially now while we’re locked down.
My fingers are crossed that Drexler finds a buyer for what he needs to break even on his shares and puts us out of our misery. I think he’s a like $1.13 or something a share.
I hope so. I’m still hopeful that they sell the brand for anything over $1.00 per share. I mean a guy can dream right?! Lol
Lolol love it
Lol GB ??
Wtf are people doing? Losing their minds? This stock is dropping line hot cakes. What am I missing? Stock has never seen these levels. Was $13 in 2016. I’m buying.
Agree. Let’s pray for a pump n dump. Hahaha I’m outta here if it breaks a dollar
I’m still here. How it goes?
Not much of anything new per se...Company being ran by a turd. Fins not released for some time. I’m hopeful that Drexler gets his head out of his arse and sells at some point. See you on some of hen other boards. Good stuff!
$20 into the bell?
That’s why I’m here. Been in this for several years now. I’m loaded and ready for the approval. I would love to see over $10 per share. That puts market cap just under $200 million. I think that or more is reasonable for an approved drug.
That wouldn’t hurt my feelings
Why would he sell at .70? Unloading company for just over $20 million, netting him $13 Million? Although I do feel there’s something with the timing in his conversion and the issuance of the board members stock awards, I don’t feel .70 a share is a realistic sell price. Maybe a realistic offer that they’ve received but not an offer that they’ll accept. $1.50? Ehhh $2.00? Ehhh optimistic? Maybe.
Do I think they could get 1x revenue for this company? Probably not...not with Drexler and his cronies running it and current financial health of the business. Do I think that another company would buy $80 to $100 million in sales for a discount at $1.5 or $2.00 a share? I do think that’s possible.
Let’s hope this thing gets our approval this year. Make that money!
It’s been a minute since I’ve reviewed the listing requirements. Do you know what the criteria is and when deadline is?
Also positive seeing the executives buying.
That’s 100 percent that way I was interpreting. This thing has taken a beating over the last few weeks. Let’s see if they can dig themselves out of this hole with some positive news.
Buy the dip? I don’t think we’re any worse off than when i originally hopped in this. No approval but a clear path to correction. Glad I averaged down yesterday and not today lol ??
I’m hopeful but the silence is brutal. Let’s hope they got their stuff together this time.
Come on execs...post some news so I can sell this pig! Wow...maybe they’ll have FDA approval before my grandkids are born! Unreal...
Come on execs...post some news so I can sell this pig! Wow...maybe they’ll have FDA approval before my grandkids are born! Unreal...
In my opinion the investor road show that they’re going to present at is an attempt to get an attractive tender offer for a buyout. I think Drexler would take one times sales without hesitation. Fully diluted is around $3.00 a share. That triples his money, plus he has all the other money he’s raped away from the company while acting as the failing CEO. If this knucklehead would put aside the greed for a second and publicly announce that he’s killing his salary until he rights the ship, at least then investors would see he’s doing his part. Look at how much people praised Donald Trump for not taking a salary while in office...I think it’s fing laughable but many Trump supporters clung to that statement thinking that he was really acting for the people. MSLP has been raped and pillaged since inception.
It definitely helped with the average. Wasn’t too crazy about dropping more loot in but planning for an exit strategy. I bought all the way up to the .80’s
Yep. Nearly doubled my position Hoping it pays of
Make it rain!!!!! ????????